| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |